Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging
Clinical trial NCT02683421 · COMPLETED
Trial details
- NCT number
- NCT02683421
- Sponsor
- Navidea Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2016-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.